Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...
Patients with early-stage Hodgkin lymphoma had impressive response rates when treated with a novel combination of ...
After a patient has undergone treatment for cancer, they may be told that the disease is either in "remission" or that they have been "cured." But there's a distinction between these terms. So what ...
CTD402, an allogeneic CAR T-cell therapy, is designed for immediate administration and targets relapsed/refractory T-ALL and ...
GlobalData on MSN
J&J’s Caplyta doubles remission rate in MDD patients
J&J presented the new analysis from three Phase III trials of Caplyta in MDD.
The study covered in this summary was published on ssrn.com as a preprint and has not yet been peer reviewed. Cytarabine plus an anthracycline has been the standard AML induction regimen for decades, ...
As soon as I entered complete remission for multiple myeloma, I felt a glimmer of hope. The word "remission" carries a sense of hope and relief, like the first ray of sunshine breaking through the ...
After announcing in March 2024 that she had been diagnosed with cancer, Kate Middleton, Princess of Wales, has again spoken out about her illness—this time, with good news. “It is a relief now to be ...
GlobalData on MSN
ImmunityBio’s allogeneic CD19 cell therapy shows complete response beyond 15 months
ImmunityBio’s stock rose nearly 40% after it announced the Phase I data and Anktiva sales figures for 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results